« Return to News | CROs/Service Providers

Innova, Goodmark Medical to set up international operations in Scotland

Wednesday, October 3, 2012 02:58 PM

Innova Partnerships, a life science investment and partnering company based in Boston and Scotland, is working Goodmark Medical of Longwood, Fla., to help them expand into international markets.

The transatlantic liaison between the two companies will bring together a high calibre senior management team to set up new operations based in Scotland and will lead Goodmark Medical's overseas efforts. The move will open up international markets for Goodmark Medical who empower patients through connected healthcare and will provide a focal point for R&D and EMEA sales.

"We are delighted to be working with Goodmark Medical as they expand their global reach,” said Steve Howell, CEO of Innova Partnerships. “Connected health is changing the way people live their lives and this is becoming especially important as we all get older."

Goodmark Medical focuses on connecting patients through building on RelayMed, a software as a service-based product that links medical diagnostics, patients and their carers.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.